approved glp 1 agonists List of and pending GLP-1 medications How Employers Can Optimize Benefits

Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls

After 56 weeks, Hb1Ac and the body weight were significantly decreased in the semaglutide group

As Emma Louise Tucker wrote in her New Rules column, if the urge to drink is dampened, your brand has to do more heavy lifting

Why the science matters for your case In pharmaceutical litigation, the science is the battlefield

It originates from the preproglucagon precursor, which undergoes enzymatic processing within intestinal L-cells, ultimately giving rise to GLP-1(1-37) and GLP-1(7-36) amide or GLP-1(7-37) peptide variants

Others describe 12+ day waits before hearing back from the medical team